Objectives: The StopSmoking Therapy, combins a motivational interview, a subcutaneous injection of NicoSan® and a hyperhydration protocol. The objectives were to evaluate the number of patients declaring cessation and factors related to relapse.
Methods: In the 18 months following protocol, 554 subjects who consented, responded to the study's questionnaire.